Skip to content

MF-15 Intraocular Lens for Patients with Mild to Moderate Glaucoma: A Clinical Study on Safety and Visual Outcomes

MF-15 Intraocular Lens for Patients with Mild to Moderate Glaucoma: A Clinical Study on Safety and Visual Outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117627
Enrollment
Unknown
Registered
2026-01-27
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary angle-closure and primary angle-closure glaucoma with cataract

Interventions

Monofocal Intraocular Lens group:N/A
MF-15 group:N/A

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with PAC or PACG who have cataracts and who have been informed and voluntarily participate in this study; 2.Age > 50 years old, no gender restrictions; 3.Preoperative intraocular pressure is stable (e.g., -12 dB. 4.Pupil diameter in the dark room ranges from 3.0 to 5.5 mm, with a kappa angle < 0.5 mm. The central corneal diameter at 4 mm shows a harmonic oscillation amplitude (HOA) < 0.3 µm. 5.Researchers communicate with patients to voluntarily select the Vivity/IQ intraocular lens based on the patient's examination reports and personal preferences. 6.Understand and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Combined progressive retinal diseases: diabetic retinopathy, macular diseases, retinitis pigmentosa, and severe optic nerve diseases; 2.History of prior intraocular surgery, patients who have undergone refractive surgery, history of ocular trauma; 3.Patients with microphthalmia, significant pupil abnormalities, severe corneal pathology, active ocular inflammation, pronounced lens zonular abnormalities, amblyopia, or systemic diseases; 4.Corneal astigmatism greater than 1 diopter or irregular astigmatism; 5.Patients with intraoperative discovery of a ruptured suspensory ligament, or severe intraoperative or postoperative complications (such as anterior capsule tear, posterior capsule rupture, anterior chamber hemorrhage, shallow postoperative anterior chamber, uncontrollably high postoperative intraocular pressure, etc.); 6.AL<20.5mm;

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;Pupil diameter;Optic Nerve Fiber Layer Thickness;Postoperative vision;Defocus curve;Anterior chamber depth;Visual Field Index;

Secondary

MeasureTime frame
Patient satisfaction;Equivalent sphere;Contrast sensitivity;

Countries

China

Contacts

Public ContactXing Xiaoli

Tianjin Medical University Eye Hospital

2218087864@qq.com+86 22 86428705

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026